Cladribine monotherapy in a patient with coexisting Crohn’s disease and multiple sclerosis
Published online on December 01, 2025
Abstract
Multiple Sclerosis Journal, Ahead of Print.
Patients with coexisting Crohn’s disease (CD) and multiple sclerosis (MS) present a complex therapeutic challenge, especially when standard dual-purpose therapies such as anti-integrins or S1P receptor modulators are contraindicated. We report the first ...
Patients with coexisting Crohn’s disease (CD) and multiple sclerosis (MS) present a complex therapeutic challenge, especially when standard dual-purpose therapies such as anti-integrins or S1P receptor modulators are contraindicated. We report the first ...